Negative impact of high body mass index on the efficacy of anti-TNFα agents in patients with Inflammatory Bowel Disease

被引：0
|
作者：
Hamoir, F. [1 ]
De Leuze, F. [1 ]
Denis, M. [1 ]
De Vroey, B. [1 ]
De Suray, N. [1 ]
Burnet, G. [1 ]
Piessevaux, H. [1 ]
Dewit, O. [1 ]
机构：
[1] Clin Univ St Luc, Gastroenterol, Brussels, Belgium
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P591
引用
收藏
页码：719 / 720
页数：2
相关论文
共 50 条
  • [41] Ustekinumab and Anti-TNF Combination Therapy in Patients with Inflammatory Bowel Disease
    Yzet, Clara
    Dupas, Jean-Louis
    Fumery, Mathurin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (05): : 748 - 749
  • [42] Lipid Profile in Inflammatory Bowel Disease Patients on Anti-TNFα Therapy
    Miranda-Bautista, Jose
    de Gracia, Celia
    Lopez-Ibanez, Maria
    Barrientos, Maria
    Marin-Jimenez, Ignacio
    Diaz-Redondo, Alicia
    Menchen, Luis
    GASTROENTEROLOGY, 2014, 146 (05) : S577 - S577
  • [43] AN AUDIT OF ADHERENCE TO ANTI-TNF THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Duncan, J.
    Sastrillo, M.
    Baker, J.
    Younge, L.
    Anderson, S.
    Lindsay, J.
    Sanderson, J.
    Irving, P.
    GUT, 2011, 60
  • [44] Lipid Profile in Inflammatory Bowel Disease Patients on Anti-TNFα Therapy
    José Miranda-Bautista
    Celia de Gracia-Fernández
    María López-Ibáñez
    María Barrientos
    Alejandra Gallo-Moltó
    Marina González-Arias
    Casilda González-Gil
    Alicia Díaz-Redondo
    Ignacio Marín-Jiménez
    Luis Menchén
    Digestive Diseases and Sciences, 2015, 60 : 2130 - 2135
  • [45] Meta-Analysis on the Efficacy of a Second-Line Anti-TNF in Inflammatory Bowel Disease Patients With Failure to a Previous Anti-TNF Treatment
    Gisbert, Javier P.
    Marin, Alicia C.
    McNicholl, Adrian G.
    Chaparro, Maria
    GASTROENTEROLOGY, 2014, 146 (05) : S247 - S247
  • [46] Meta-analysis of the efficacy of a second-line anti-TNF in inflammatory bowel disease patients with failure to a previous anti-TNF treatment
    Gisbert, J. P.
    Marin, A.
    McNicholl, A.
    Chaparro, M.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S237 - S237
  • [47] Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study
    Marin-Jimenez, Ignacio
    Bastida, Guillermo
    Fores, Ana
    Garcia-Planella, Esther
    Arguelles-Arias, Federico
    Sarasa, Pilar
    Tagarro, Ignacio
    Fernandez-Nistal, Alonso
    Montoto, Carmen
    Aguas, Mariam
    Santos-Fernandez, Javier
    Bosca-Watts, Marta Maia
    Ferreiro, Rocio
    Merino, Olga
    Aldeguer, Xavier
    Cortes, Xavier
    Sicilia, Beatriz
    Mesonero, Francisco
    Barreiro-de Acosta, Manuel
    BMJ OPEN GASTROENTEROLOGY, 2020, 7 (01):
  • [48] Tuberculin skin test conversion rate in inflammatory bowel disease patients receiving anti-TNFα agents
    Fragaki, M.
    Paspatis, G.
    Karmiris, K.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S375 - S375
  • [49] The Long-Term Influence of Anti-TNF Agents on Hemoglobin Levels in Patients With Inflammatory Bowel Disease
    Koutroubakis, Ioannis E.
    Rivers, Claudia Ramos
    Regueiro, Miguel
    Koutroumpakis, Efstratios
    Click, Benjamin H.
    Schwartz, Marc
    Swoger, Jason M.
    Baidoo, Leonard
    Hashash, Jana G.
    Barrie, Arthur
    Dunn, Michael A.
    Binion, David G.
    GASTROENTEROLOGY, 2015, 148 (04) : S463 - S463
  • [50] Do Anti-TNF Agents Affect Postoperative Outcomes in Patients Undergoing Surgery for Inflammatory Bowel Disease?
    Divino, Celia M.
    Shwaartz, Chaya
    Fields, Adam C.
    Sobrero, Maximiliano
    Cohen, Brian
    GASTROENTEROLOGY, 2016, 150 (04) : S1261 - S1261
12345